TAKING THE COMPREHENSIVE CLINICAL SCIENCE SELF-ASSESSMENT
With the Comprehensive Clinical Science Self-Assessment, you can evaluate your readiness, reinforce your knowledge, and maximize study time ahead of the USMLE® Step 2 CK.
Overview
The Comprehensive Clinical Science Self-Assessment is a practice test designed for students planning to take the USMLE Step 2 CK. It features multiple-choice questions on content typically covered during the core clinical clerkships.
In addition to helping you gain a familiarity with NBME-style questions, the Comprehensive Clinical Science Self-Assessment enables you to:
Evaluate your readiness to take the USMLE Step 2 CK
Target your studies using diagnostic feedback highlighting areas of strength and weakness
View answer explanations to reinforce your knowledge and maximize study time
Use your self-assessment score to estimate your approximate score on the USMLE score scale
Format
There are multiple forms available for the Comprehensive Clinical Science Self-Assessment, each containing 200 multiple-choice questions.
You can choose to take your self-assessment in either a standard-paced or self-paced format.
The standard-paced option mimics a live testing environment and contains four sections of 50 questions. You have up to 1 hour and 15 minutes to complete each section.
The self-paced option also contains four sections of 50 questions, but allows you up to 5 hours to complete each section.
Recent Updates
INSIGHTSSM
INSIGHTS is a new, interactive tool designed to give you a clearer picture of your performance and readiness for the USMLE or a Clinical Science Subject Exam.
Sort, filter, and compare your self-assessment results for a better understanding of your progress
Dig deeper into specific content topics, time spent per question, and more with enhanced question review options
View trends in your overall and content area performance across multiple takes of the same exam
Review all your self-assessment results and answer explanations in one place
Reviews
There are no reviews yet.